申请人:AVENTIS PHARMACEUTICALS INC.
公开号:US20040102450A1
公开(公告)日:2004-05-27
This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa..
这项发明涉及抑制因子Xa的氧杂杂环化合物,抑制同时抑制因子Xa和因子IIa的氧杂杂环化合物,包含这些化合物的药物组合物,用于制备这些化合物的中间体,直接抑制因子Xa的方法,以及同时直接抑制因子Xa和因子IIa的方法。